{
  "pmcid": "11073793",
  "sha256": "167247deb828c08ccce2442b560a25e73f96b5994fdb5cf8486bb49fa3106549",
  "timestamp_utc": "2025-11-09T21:59:56.056821+00:00",
  "model_used": "gpt-4o",
  "readability": {
    "flesch_kincaid": 12.898965517241379,
    "reading_ease": 19.800919540229927,
    "word_count": 232
  },
  "consort_scores": {
    "rubric_version": "v3.0-2025-10-14",
    "items": {
      "Title": {
        "score": 1,
        "evidence": "Randomised Controlled Trial of Intraoperative Molecular Imaging in Malignant Pulmonary Nodule Detection"
      },
      "Trial_Design": {
        "score": 1,
        "evidence": "Participants underwent preoperative PET and were randomized to receive OTL38 prior to pulmonary resection."
      },
      "Participants": {
        "score": 2,
        "evidence": "Eligibility criteria included patients with imaging features suggestive of malignancy. The study was conducted at a tertiary care center."
      },
      "Intervention": {
        "score": 2,
        "evidence": "Participants underwent preoperative PET and were randomized to receive OTL38 prior to pulmonary resection."
      },
      "Objective": {
        "score": 1,
        "evidence": "This study evaluates whether intraoperative molecular imaging (IMI) with a folate receptor-targeted near-infrared contrast agent (OTL38) enhances the detection of malignant pulmonary nodules compared to 18 Fluorodeoxyglucose positron emission tomography (PET)."
      },
      "Method_Outcome": {
        "score": 1,
        "evidence": "The primary outcome was the detection rate of malignant nodules, measured intraoperatively."
      },
      "Randomisation_Allocation": {
        "score": 2,
        "evidence": "Randomization was computer-generated, and allocation was concealed."
      },
      "Blinding": {
        "score": 0,
        "evidence": "Blinding was not applicable."
      },
      "Number_Randomised": {
        "score": 1,
        "evidence": "Fifty patients with pulmonary nodules suspicious for malignancy were enrolled."
      },
      "Number_Analysed": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Result_Outcome": {
        "score": 3,
        "evidence": "Sensitivity of IMI and PET were 95.6% and 73.5% (p=0.001), respectively. Positive predictive values were 94.2% and 89.3% (p>0.05)."
      },
      "Harms": {
        "score": 1,
        "evidence": "No adverse events were reported."
      },
      "Trial_Registration": {
        "score": 0,
        "evidence": "Trial registration: N/A."
      },
      "Funding": {
        "score": 0,
        "evidence": "Funding: N/A."
      }
    },
    "total_score": 15,
    "max_score": 25
  }
}